Your World of Legal Intelligence
 United Kingdom | +44 (0) 20 7284 8080

Cadence Expands Pfizer's License to Molecular Design Software.

Document Cited in Related
Vincent

ENPNewswire-October 26, 2023--Cadence Expands Pfizer's License to Molecular Design Software

(C)2023 ENPublishing - http://www.enpublishing.co.uk

Release date- 25102023 - SAN JOSE - Cadence Molecular Sciences (OpenEye)-a business unit ofCadence Design Systems (Nasdaq: CDNS)-announced today that Pfizer Inc. has signed an agreement to extend and expand access to Cadence products and programming toolkits for advanced molecular design.

'We're excited to continue to support Pfizer as they innovate across their therapeutic portfolio, utilizing this unique set of research tools to aid in their early-stage drug discovery process,' said Anthony Nicholls, PhD, corporate vice president, Cadence Molecular Sciences. 'As we expand this agreement with Pfizer, we hope to continue to enable high-quality science at the frontier of medicine.'

Cadence Molecular Sciences' physics-and AI-based modeling and cheminformatics computational software is an enabler of early-stage drug discovery innovation. The software is used by major pharmaceutical and biotech companies worldwide to help accelerate and advance therapeutic research.

'Cadence's molecular design technology continues to be an important resource to help us progress our early scientific discovery efforts across our therapeutic portfolio,' said Sergio Rotstein, vice...

To continue reading

Request your trial
COPYRIGHT Normans Media Ltd.

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT